Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | The importance of genomic characterization in T-ALL

David Teachey • 12 Jun 2022
EHA 2022
Acute Lymphoblastic Leukemia Leukemia Rare Diseases

David Teachey, MD, The Perelman School of Medicine at The University of Pennsylvania, Philadelphia, PA, discusses the role of genomic characterization in T-cell acute lymphoblastic leukemia (T-ALL) both at diagnosis and at relapse. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from David Teachey

1:50
Identifying new subtype-defining lesions in pediatric T-ALL
David Teachey • 12 Jun 2022
1:08
Unmet needs in T-ALL: targeted therapies & managing relapse
David Teachey • 12 Jun 2022

Related Videos

3:23
Molecular characteristics associated with increased risk of disease progression in SMM
Mark Bustoros • 27 Sep 2023
2:25
Biomarkers of progression and risk stratification in asymptomatic Waldenström's macroglobulinemia
Mark Bustoros • 27 Sep 2023
2:05
Investigating mutation order in AML using single-cell sequencing
Ravindra Majeti • 8 Apr 2024
3:12
An epitope editing approach to enable the use of targeted immunotherapy in AML
Gabriele Casirati • 9 Apr 2024
The content of VJHemOnc is intended for healthcare professionals